Table 3.

Comparison of BC-associated PVs prevalence among older and younger women with TNBC

Gene	Total n= 389 (%)	≤60 y n=373 (%)	>60 y n = 16 (%)	P (≤ 60 vs > 60 y)
BRCA1	294 (75.5)	288 (77.2)	6 (37.5)	< 0.01
BRCA2	63 (16.1)	58 (15.5)	5 (31.2)	0.09
Non-BRCA:	32 (8.2)	27 (7.2)	5 (31.2)	< 0.01
ATM	1 (0.2)	0	1 (6.25)
BARD1	2 (0.5)	2 (0.5)	0
BRIP1	2 (0.5)	2 (0.5)	0
CHEK2	3 (0.7)	3 (0.8)	0
PALB2	13 (3.3)	11 (2.9)	2 (12.5)
PTEN	1 (0.2)	1 (0.2)	0
RAD50	1 (0.2)	1 (0.2)	0
RAD51C	4 (1.0)	3 (0.8)	2 (12.5)
RAD51D	3 (0.7)	3 (0.8)	0
TP53	1 (0.2)	1 (0.2)	0